Denied

No. 19-1073

Enzo Life Sciences, Inc. v. Roche Molecular Systems, Inc., et al.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

DISTRIBUTED for Conference of 3/27/2020.

Waiver of right of respondents Roche Molecular Systems, Inc.; Roche Diagnostics Corporation; Roche Diagnostics Operations, Inc.; Roche Nimblegen, Inc.; Becton, Dickinson and Company; Becton Dickinson Diagnostics Inc.; and Geneohm Sciences Inc. to respond filed.

Waiver of right of respondents Abbott Laboratories; Abbott Molecular, Inc. to respond filed.

Petition for a writ of certiorari filed. (Response due April 1, 2020)

Application (19A800) granted by The Chief Justice extending the time to file until February 26, 2020.

Application (19A800) to extend the time to file a petition for a writ of certiorari from January 27, 2020 to February 26, 2020, submitted to The Chief Justice.

Parties

Enzo Life Sciences, Inc, Petitioner, represented by Justin Patrick Daniel Wilcox

Abbott Laboratories; Abbott Molecular, Inc., Respondent, represented by John Caviness O'Quinn

Roche Molecular Systems, Inc.; Roche Diagnostics Corporation; Roche Diagnostics Operations, Inc.; Roche Nimblegen, Inc.; Becton, Dickinson and Company; Becton Dickinson Diagnostics Inc.; and Geneohm Sciences Inc., Respondent, represented by Thomas Glenn Saunders

 
Last updated: May 24, 2020